Mirum Pharmaceuticals, Inc. · NASDAQ:MIRM
Peetz Christopher exercised options for 12,197 Mirum Pharmaceuticals, Inc. shares (Form 4)
Traded Oct 6, 2026 · Filed Oct 6, 2026
On Oct 6, 2026, Peetz Christopher (Director, CHIEF EXECUTIVE OFFICER) exercised options for 12,197 Mirum Pharmaceuticals, Inc. shares at an average US$17.31 for US$211K, leaving 206,637 shares. Filed Oct 6, 2026 (Form 4).
- Options exercised
- 12,197 shares
- Price
- US$17.31 average (US$15.87 to US$19.19)
- Value
- US$211K
- Holding after
- 206,637 shares
- Trading plan
- No
- Role
- Director, CHIEF EXECUTIVE OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 6, 2026 | Common Stock | Option exercise | 5,305 | US$19.19 | 199,745 | Direct |
| Oct 6, 2026 | Common Stock | Option exercise | 6,892 | US$15.87 | 206,637 | Direct |
Source
Related
- Mirum Pharmaceuticals, Inc.
- Peetz Christopher
- Mirum Pharmaceuticals, Inc. shareholders
- Form 4 · Peetz Christopher · Sep 3, 2026
- Form 4 · Peetz Christopher · Aug 11, 2026
- Form 4 · Peetz Christopher · Jul 8, 2026
- Form 4 · Peetz Christopher · Jun 2, 2026
- Form 4 · Howe Jolanda · Oct 19, 2026
- Form 4 · Bjerkholt Eric · Sep 15, 2026
- Form 4 · Howe Jolanda · Sep 3, 2026
- Form 4 · Howe Jolanda · Aug 19, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026